Industry
152d agoEli Lilly Invests $2.75B in AI Drug Development
A landmark $2.75 billion partnership between Eli Lilly and Insilico Medicine signals a global shift toward AI‑driven drug discovery. The collaboration will accelerate the development of novel therapies, reduce research timelines, and lower costs across the pharmaceutical industry.
The Signal
By integrating advanced machine‑learning models, the deal could reshape how medicines are discovered worldwide ahead.